Cited 14 time in
Mutation of purD and purF genes further attenuates Brucella abortus strain RB51
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Quang Lam Truong | - |
| dc.contributor.author | Cho, Youngjae | - |
| dc.contributor.author | Barate, Abhijit Kashinath | - |
| dc.contributor.author | Kim, Suk | - |
| dc.contributor.author | Watarai, Masahisa | - |
| dc.contributor.author | Hahn, Tae-Wook | - |
| dc.date.accessioned | 2022-12-26T21:49:44Z | - |
| dc.date.available | 2022-12-26T21:49:44Z | - |
| dc.date.issued | 2015-02 | - |
| dc.identifier.issn | 0882-4010 | - |
| dc.identifier.issn | 1096-1208 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/17430 | - |
| dc.description.abstract | In the present study, transposon mutagenesis was used to further attenuate Brucella abortus RB51 vaccine strain. Two purD and purF mutants were constructed, characterized and evaluated for attenuation via intracellular survival in murine macrophage-like RAW264.7 and HeLa cells, and by clearance in BALB/c mice. The purD and purF mutants showed significantly decreased intracellular survival, and complementation of these mutants with intact copies of purD or purF genes of RB51 strain was able to restore these defects. In addition, the pur mutants presented significantly lowered persistence in mice. Immunization with purD and purF mutants protected mice against a challenge with the virulent B. abortus strain 544 at a level similar to that of the parent RB51. These data suggest that genes encoding the early stages of purine biosynthesis (purD and purF) are required for intracellular survival and virulence of B. abortus. (C) 2014 Elsevier Ltd. All rights reserved. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD | - |
| dc.title | Mutation of purD and purF genes further attenuates Brucella abortus strain RB51 | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1016/j.micpath.2014.12.003 | - |
| dc.identifier.scopusid | 2-s2.0-84920286051 | - |
| dc.identifier.wosid | 000350708400001 | - |
| dc.identifier.bibliographicCitation | MICROBIAL PATHOGENESIS, v.79, pp 1 - 7 | - |
| dc.citation.title | MICROBIAL PATHOGENESIS | - |
| dc.citation.volume | 79 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 7 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Immunology | - |
| dc.relation.journalResearchArea | Microbiology | - |
| dc.relation.journalWebOfScienceCategory | Immunology | - |
| dc.relation.journalWebOfScienceCategory | Microbiology | - |
| dc.subject.keywordPlus | SALMONELLA-TYPHIMURIUM | - |
| dc.subject.keywordPlus | PROTECTIVE IMMUNITY | - |
| dc.subject.keywordPlus | MOUSE MODEL | - |
| dc.subject.keywordPlus | VACCINE | - |
| dc.subject.keywordPlus | MUTANTS | - |
| dc.subject.keywordPlus | VIRULENCE | - |
| dc.subject.keywordPlus | THIAMINE | - |
| dc.subject.keywordPlus | CATTLE | - |
| dc.subject.keywordPlus | MICE | - |
| dc.subject.keywordPlus | MELITENSIS | - |
| dc.subject.keywordAuthor | Brucella abortus RB51 vaccine strain | - |
| dc.subject.keywordAuthor | Transposon mutagenesis | - |
| dc.subject.keywordAuthor | Purine biosynthesis | - |
| dc.subject.keywordAuthor | Virulence | - |
| dc.subject.keywordAuthor | Protection | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
